Kbc Group Nv Zoetis Inc. Transaction History

Kbc Group Nv

$37 Billion
Q2 2025

A detailed history of Kbc Group Nv transactions in Zoetis Inc. stock. As of the latest transaction made, Kbc Group Nv holds 340,527 shares of ZTS stock, worth $40.5 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

340,527

Previous 315,823 7.82%

Holding current value

$40.5 Million

Previous $52 Million 2.13%

% of portfolio

0.14%

Previous 0.16%

47 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	BUY	$144.41 - $170.3 $3.57 Million - $4.21 Million	24,704 Added 7.82%	340,527 $53.1 Million
Q1 2025 Apr 25, 2025	BUY	$156.48 - $175.67 $6.1 Million - $6.85 Million	39,007 Added 14.09%	315,823 $52 Million
Q4 2024 Jan 22, 2025	SELL	$162.24 - $194.42 $16 Million - $19.1 Million	-98,351 Reduced 26.22%	276,816 $45.1 Million
Q3 2024 Nov 06, 2024	BUY	$172.58 - $196.48 $2.44 Million - $2.78 Million	14,159 Added 3.92%	375,167 $73.3 Million
Q2 2024 Jul 17, 2024	BUY	$145.54 - $178.83 $3.47 Million - $4.27 Million	23,861 Added 7.08%	361,008 $62.6 Million
Q1 2024 May 08, 2024	BUY	$165.67 - $199.94 $8.78 Million - $10.6 Million	52,995 Added 18.65%	337,147 $57 Million
Q4 2023 Feb 13, 2024	SELL	$151.44 - $200.09 $39.8 Million - $52.6 Million	-263,096 Reduced 48.08%	284,152 $56.1 Million
Q3 2023 Feb 15, 2024	BUY	$167.14 - $192.77 $364,866 - $420,816	2,183 Added 0.39%	556,957 $96.9 Million
Q2 2023 Feb 15, 2024	SELL	$160.94 - $186.23 $22.3 Million - $25.8 Million	-138,574 Reduced 19.99%	554,774 $95.5 Million
Q2 2023 Jul 28, 2023	BUY	$160.94 - $186.23 $32.6 Million - $37.7 Million	202,290 Added 58.64%	547,248 $94.2 Million
Q1 2023 Feb 14, 2024	BUY	$145.48 - $175.02 $5.44 Million - $6.54 Million	37,383 Added 11.97%	349,664 $58.2 Million
Q1 2023 May 04, 2023	SELL	$145.48 - $175.02 $49.6 Million - $59.7 Million	-341,183 Reduced 49.72%	344,958 $57.4 Million
Q4 2022 Feb 14, 2024	SELL	$131.14 - $157.47 $75.8 Million - $91 Million	-577,765 Reduced 64.91%	312,281 $45.8 Million
Q3 2022 Feb 15, 2024	BUY	$148.29 - $182.55 $60.7 Million - $74.7 Million	409,196 Added 144.01%	693,348 $103 Million
Q3 2022 Nov 08, 2022	SELL	$148.29 - $182.55 $29 Million - $35.7 Million	-195,402 Reduced 22.17%	686,141 $102 Million
Q2 2022 Feb 14, 2024	SELL	$155.97 - $200.09 $13.4 Million - $17.2 Million	-85,768 Reduced 8.79%	890,046 $153 Million
Q2 2022 Jul 26, 2022	SELL	$155.97 - $200.09 $14.7 Million - $18.9 Million	-94,271 Reduced 9.66%	881,543 $152 Million
Q1 2022 Feb 14, 2024	SELL	$181.39 - $234.03 $27.1 Million - $35 Million	-149,529 Reduced 13.29%	975,814 $184 Million
Q1 2022 May 06, 2022	SELL	$181.39 - $234.03 $27.1 Million - $35 Million	-149,529 Reduced 13.29%	975,814 $184 Million
Q4 2021 Feb 14, 2024	BUY	$193.69 - $247.03 $163 Million - $208 Million	841,191 Added 296.04%	1,125,343 $275 Million
Q4 2021 Feb 03, 2022	BUY	$193.69 - $247.03 $77.7 Million - $99.1 Million	401,022 Added 55.37%	1,125,343 $275 Million
Q3 2021 Nov 10, 2021	BUY	$189.29 - $209.69 $18.2 Million - $20.2 Million	96,310 Added 15.34%	724,321 $135 Million
Q2 2021 Aug 11, 2021	BUY	$155.9 - $187.99 $24.5 Million - $29.5 Million	157,154 Added 33.38%	628,011 $117 Million
Q1 2021 Apr 26, 2021	BUY	$144.0 - $169.39 $10.9 Million - $12.8 Million	75,564 Added 19.12%	470,857 $74.2 Million
Q4 2020 Feb 10, 2021	BUY	$157.07 - $174.35 $30.1 Million - $33.4 Million	191,414 Added 93.89%	395,293 $65.4 Million
Q3 2020 Oct 28, 2020	SELL	$137.1 - $165.37 $4.55 Million - $5.49 Million	-33,189 Reduced 14.0%	203,879 $33.7 Million
Q2 2020 Aug 10, 2020	SELL	$111.92 - $142.53 $206,828 - $263,395	-1,848 Reduced 0.77%	237,068 $32.5 Million
Q1 2020 May 04, 2020	SELL	$92.66 - $144.94 $1.12 Million - $1.76 Million	-12,141 Reduced 4.84%	238,916 $28.1 Million
Q4 2019 Feb 11, 2020	BUY	$116.25 - $133.25 $2.03 Million - $2.33 Million	17,503 Added 7.49%	251,057 $33.2 Million
Q3 2019 Nov 07, 2019	BUY	$112.57 - $128.43 $26.2 Million - $29.9 Million	232,594 Added 24228.54%	233,554 $29.1 Million
Q2 2019 Dec 03, 2019	SELL	$97.98 - $114.28 $26.1 Million - $30.4 Million	-266,111 Reduced 99.64%	960 $109,000
Q2 2019 Jul 30, 2019	BUY	$97.98 - $114.28 $26.1 Million - $30.4 Million	266,111 Added 27719.9%	267,071 $0
Q1 2019 Dec 03, 2019	SELL	$81.56 - $100.67 $17.8 Million - $22 Million	-218,296 Reduced 99.56%	960 $97,000
Q1 2019 May 10, 2019	BUY	$81.56 - $100.67 $17.8 Million - $22 Million	218,296 Added 22739.17%	219,256 $0
Q4 2018 Dec 03, 2019	SELL	$79.28 - $95.27 $16.3 Million - $19.6 Million	-205,552 Reduced 99.54%	960 $82,000
Q4 2018 Jan 31, 2019	BUY	$79.28 - $95.27 $16.3 Million - $19.6 Million	205,552 Added 21411.67%	206,512 $17.7 Million
Q3 2018 Dec 03, 2019	SELL	$83.5 - $93.23 $22.9 Million - $25.5 Million	-273,762 Reduced 99.65%	960 $88,000
Q3 2018 Nov 14, 2018	BUY	$83.5 - $93.23 $22.9 Million - $25.5 Million	273,762 Added 28516.88%	274,722 $0
Q2 2018 Dec 03, 2019	SELL	$79.9 - $89.2 $19.9 Million - $22.2 Million	-249,001 Reduced 99.62%	960 $82,000
Q2 2018 Aug 03, 2018	BUY	$79.9 - $89.2 $19.9 Million - $22.2 Million	249,001 Added 25937.6%	249,961 $0
Q1 2018 Dec 03, 2019	SELL	$71.51 - $84.69 $12.7 Million - $15.1 Million	-178,286 Reduced 99.46%	960 $80,000
Q1 2018 May 09, 2018	BUY	$71.51 - $84.69 $12.7 Million - $15.1 Million	178,286 Added 18571.46%	179,246 $0
Q4 2017 Dec 03, 2019	SELL	$63.24 - $72.8 $15.1 Million - $17.4 Million	-239,051 Reduced 99.6%	960 $69,000
Q4 2017 Feb 07, 2018	BUY	$63.24 - $72.8 $15.1 Million - $17.4 Million	239,051 Added 24901.15%	240,011 $0
Q3 2017 Dec 03, 2019	SELL	$59.73 - $65.4 $24.4 Million - $26.7 Million	-408,632 Reduced 99.77%	960 $61,000
Q3 2017 Nov 13, 2017	BUY	$59.73 - $65.4 $24.4 Million - $26.7 Million	408,632 Added 42565.83%	409,592 $0
Q2 2017 Dec 03, 2019	BUY	N/A	960	960 $60,000

Others Institutions Holding ZTS

# of Institutions

2,088

Shares Held

423M

Call Options Held

1.87M

Put Options Held

1.96M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $55.6B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account